v3.26.1
Sale of RPK - Schedule of Consolidated Statements of Loss and Comprehensive Loss (Details) - Bophelo Bio Science and Wellness (Pty) Ltd. ("Bophelo")
12 Months Ended
Dec. 31, 2025
USD ($)
Schedule of Consolidated Statements of Loss and Comprehensive Loss [Line Items]  
Cash received $ 2,000,000
Finder’s fee – transaction cost (446,250)
Consideration received, net 1,553,750
Cash 105,175
Accounts receivable 158,812
Inventory 895,715
Prepayments 33,762
Property, plant and equipment, net 1,769,221
Intangible licenses 3,783,117
Accounts payable (2,016,744)
Bank loans (3,374,088)
Net assets sold 1,354,970
Gain on sale of subsidiary $ 198,780